Agency to Consider Silodosin to Treat BPH
The FDA has accepted a New Drug Application for silodosin, a novel alpha1-adrenoreceptor antagonist, from Watson Pharmaceuticals, Inc., of Corona, Calif. Watson is seeking approval of silodosin for the treatment of BPH symptoms.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.